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Abstract 
Mycobacterium tuberculosis, the bacterium that causes tuberculosis, can enter non-growing 
states in which it is phenotypically tolerant of antibiotics. These states are characterized by reduced 
metabolic activity, and occur in response to stressors encountered in the body, such as hypoxia 
and starvation. Both M. tuberculosis and its non-pathogenic relative M. smegmatis have been shown 
to stabilize their mRNA transcripts under growth-inhibiting conditions. One explanation for this 
phenomenon could be a decrease in the intracellular levels of mRNA degradation proteins. In the 
present research, several proteins fitting that description were epitope-tagged and their abundance 
measured under stress. Our results suggest that RNase E may be specifically downregulated in 
hypoxia.  
 
Introduction 
 
Though great strides have been made in recent decades, tuberculosis continues to pose a 
threat worldwide. The World Health Organization estimates that in 2014, 9.6 million people were 
infected and 1.5 million died of the disease (WHO, 2015). One of the major obstacles to treating 
tuberculosis is the bacteria’s tendency toward a state of near-dormancy described as quiescence, 
which has been observed for some time in the laboratory (Wayne, 1976) and is distinguished from 
true dormancy by the continued presence of (a reduced amount of) ATP (Gengenbacher et al., 
2010), low-level respiratory functions, and maintenance of membrane potential (Rao et al., 2008). 
A quiescent state can lead to a transient, non-heritable form of antibiotic resistance termed 
antibiotic tolerance (Levin & Rozen, 2006). There are several proposed mechanisms for this 
phenomenon, but a particularly compelling explanation is based on the decrease in bacterial 
metabolic activity. As early as 1944, researchers had begun to explore this explanation, with a 
finding that penicillin only killed Staphylococcus aureus in its actively growing state (Lee, Foley, & 
Epstein, 1944). More recently, this effect has been observed in mycobacteria, with a finding that 
Mycobacterium tuberculosis shows reduced killing from certain antibiotics after six weeks of starvation 
(Betts et al., 2002). Some researchers have also begun to explore the possibility that active 
remodeling of metabolic pathways also contributes to this antibiotic tolerance (Nguyen et al., 
2011). 
Due in part to the bacterium’s ability to enter this quiescent state, treatment for tuberculosis 
is only successful when patients adhere to a lengthy course of antibiotics (Thomas et al., 2005). 
Noncompliance occurs at high rates, particularly among vulnerable populations and in patients 
who lack easy access to a clinic (Brudney & Dobkin, 1991; Shargi & Lindtjørn, 2007). Additionally, 
temporary physiological antibiotic tolerance in protected sub-populations of bacteria can lead to 
greater rates of genetic antibiotic resistance (Levin & Rozen, 2006). The granulomas that occur in 
tuberculosis are thought to induce this state, and typical research parameters to mimic those 
conditions include hypoxia (Wayne & Hayes, 2003) and nutrient starvation (Betts et al., 2002). 
These problems point to a need for the development of faster-working tuberculosis 
treatments, particularly treatments capable of interfering with the quiescent state. In order to 
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achieve this, it is necessary to conduct significant further research into the mechanisms that allow 
bacteria to enter this non-growing state. 
Research in a variety of bacterial species has suggested that mRNA transcript half-lives are 
increased when growth is arrested; this is referred to as mRNA stabilization. In Bacillus subtilis, 
transcripts expressed in the stationary phase had half-lives as much as 15 times longer than 
transcripts expressed during the exponential phase (Resnekov et al., 1990). In E. coli, the mRNA 
encoding a ribosome modulation factor was found to be stabilized during stationary phase (Aiso 
et al., 2005), and other research determined that anaerobic conditions caused slowing of mRNA 
turnover (Georgellis et al., 1993). Increased mRNA half-life during nutrient starvation has been 
observed in Lactococcus lactis (Redon et al. 2005, Dressaire et al. 2013), Rhizobium leguminosarum 
(Thorne & Williams 1997), and Vibrio sp. S14 (Nyström et al. 1990). In M. tuberculosis, hypoxic 
conditions induce mRNA stabilization (Rustad et al., 2012). Preliminary results from the Shell lab 
show similar results in M. smegmatis, a fast-growing non-pathogenic relative of M. tuberculosis, under 
conditions of hypoxia and carbon starvation. mRNA stabilization may be important for 
conserving energy in the presence of limited resources. 
Beginning with E. coli, researchers have identified bacterial protein complexes, referred to 
as degradosomes, that are major participants in the process of mRNA degradation. Two major 
components of the degradosome in E. coli are RNase E, an essential endonuclease, and 
polynucleotide phosphorylase (PNPase) (Miczak et al., 1996). The propensity of bacterial 
degradation proteins to function in complexes seems to be conserved across many bacterial 
classes, with a similar complex having been identified in S. aureus (Roux et al., 2011) and a more 
transiently-associated complex characterized in B. subtilis (Cascante-Estepa et al., 2016; Lehnik-
Habrink et al., 2010). Homologs of some of the E. coli degradosome component proteins exist in 
mycobacteria, including RNase E and PNPase (Kovacs et al., 2005, Unciuleac & Shuman, 2013). 
RNase J has also been identified as a protein involved in RNA degradation in Mycobacteria 
(Taverniti et al. 2011). However, it is unknown if these proteins function in complexes. 
In the published literature that details transcriptome-wide analyses of M. tuberculosis under 
stress, there has been no identification of any alteration in the abundance of mRNA transcripts 
encoding RNases. However, under conditions of both hypoxia and nutrient starvation, several 
genes predicted to encode RNA helicases have been shown to down-regulated (Betts et al., 2002; 
Sherman et al, 2001). Helicases are known to be involved in RNA degradation and are constituents 
of the E. coli degradosome (reviewed in Houseley & Tollervey, 2009).  
Recent research from Schubert et al. (2015) has yielded data regarding protein abundance 
in M. tuberculosis throughout hypoxic growth. The proteome-wide analysis does not show any 
significant difference in RNase protein levels in hypoxic growth as compared to log phase; 
however, the RNA helicase RhlE had decreased abundance in hypoxia, consistent with previously 
published transcriptional data (Betts et al., 2002).  
The present research investigates whether levels of RNA degradation proteins are altered 
under hypoxic conditions in mycobacteria, in order to determine whether the levels of these 
proteins could be a factor in mRNA stabilization. Using M. smegmatis, several proteins associated 
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with RNA degradation (including RNase E, RNase J, and a putative RNA helicase) were epitope-
tagged for quantification via western blot under conditions associated with quiescence.  
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Materials & Methods 
 
Incubation 
All liquid cultures were incubated at 37° C in a Lab-Line® incubator-shaker set to 175 rpm. 
M. smegmatis was grown in 7H9 supplemented with glycerol, 0.05% Tween 80, Bovine Serum 
Albumin Fraction V, NaCl, and catalase. E. coli was grown in LB broth. All plates were incubated 
in a dedicated warm room kept at 37° C. M. smegmatis was grown on 7H10 plates and E. coli was 
grown on LB agar plates. 
 
Oligos 
Primers and oligos were synthesized by IDT and resuspended at 100 μM in Qiagen elution 
buffer. Further dilutions were made with ultra-pure water. 
 
PCR 
PCR was done in 25 μl reactions with 2.5μl 10x NEB Taq buffer, 0.125 μl NEB Taq 
polymerase, 0.5 μl of each primer (10 μM), 0.5 μl of dNTPs and 1 μl of template DNA. Primers 
are listed in table 2. 
 
E. coli Transformation 
Transformation of E. coli was done with 12 μl of NEB 5-alpha competent cells and 1 μl of 
plasmid. Cells were incubated for 30 minutes on ice, heat-shocked for 30 seconds in a 42° C water 
bath, and then incubated for 5 more minutes on ice. 200 μl of SOC media was added, and then 
tubes were placed in the 37° C warm room and rotated for 1.5 hours. 150 μl and 20 μl of the 
transformation was plated on two plates.  
 
M. smegmatis Electrocompetent Cells 
Unless otherwise specified, M. smegmatis electrocompetent cells were made by washing 
overnight cultures of mc2155 with 10% glycerol. Cultures were grown from glycerol stocks 
overnight in 7H9. The cultures were pelleted at 3900 rpm, the supernatant was discarded, and the 
pellet was resuspended in a volume of 10% glycerol equivalent to the volume of the initial culture. 
This is done twice. The process is then repeated, but the cells are resuspended in 10% of initial 
volume, and then finally 1% of initial volume. 
 
M. smegmatis Transformation 
Basic (non-recombineering) transformation of M. smegmatis was done using 30-50 μl of 
competent cells and around 200 ng of plasmid, which were transferred to an electroporation 
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cuvette and electroporated at 2.5 kV with a Bio-Rad MicroPulser™. The mixture was then 
transferred into new 1.5 ml Eppendorf tubes and rotated for 2-4 hours at 37° C, then plated on 
7H10 plates with appropriate antibiotic concentration (see table 1).  
 
 E. coli M. smegmatis 
Kanamycin 50 μg/ml 20 μg/ml 
Chloramphenicol 34 μg/ml not used 
Hygromycin 150 μg/ml 150 μg/ml 
 
Recombineering 
The recombineering system used was the ORBIT system, developed by Kenan Murphy at 
the University of Massachusetts Medical School, and plasmids were obtained from his lab. 
Plasmids used were pKM444 and pKM461 (plasmids for facilitating recombineering expressing 
RecT and Bxb1 integrase; kanamycin resistant) and pKM446 (plasmid containing epitope tag; 
hygromycin and chloramphenicol resistant). pKM461 differs from pKM444 by presence of sacR 
and sacB, counterselectable markers for sucrose. 
Production of more plasmid was accomplished through transformation of 1 μl plasmid into 
12 μl NEB 5-alpha competent cells, following above protocol. Plasmid extraction was done using 
either the Qiagen or Zymo Research miniprep kit, following the respective manufacturers’ 
instructions.  
Epitope tagging the proteins was accomplished through recombineering based on protocols 
in Murphy et al. 2015 and advisory from the Murphy lab. 5 ml cultures of strains of mc2155 
transformed with pKM461 were grown up overnight, then scaled up to a culture with 5 ml per 
transformation + an additional 5 ml. At an OD of 0.5, cultures were induced with 500 ng/ml ATc 
and placed back in the shaker for an additional 3 hours. The cells were then made 
electrocompetent as described above, without the final step of resuspending in 1% of the original 
volume, so the cells remained at 10% of their original volume. Additionally, tubes remained on 
ice during the competent cell procedure and spins were done at 4° C. 400 μl of the competent 
cells were used for each transformation, which was done with 400 ng of pKM446 and 1 μg of 
recombineering oligo (see below for description; sequences in table 2). An additional control 
transformation contained plasmid but no oligo. The transformations were done at 2.5 kV, 1000 
Ω, and 25 μF. The results were transferred to a tube containing 2 ml 7H9 and rotated overnight 
(12-16 hours) and then plated on 7H10 plates with hygromycin.  
Table 1: Concentrations of antibiotic used in liquid culture 
and plates. 
6 
 
 
Figure 1: Schematic of the ORBIT recombineering system. First, the recombineering plasmid 
(encoding RecT and Bxb1 integrase, which facilitate incorporation of DNA into the genome, and 
the counterselectable marker SacRB) is transformed into the lab strain of M. smegmatis. Then a 
second transformation includes the oligo containing the attP site and homology to the target site in 
the chromosome and the plasmid containing the FLAG tag. RecT facilitates the integration of the 
oligo into the bacterial genome (detailed diagram of this process in Figure 2). The Bxb1 integrase 
then facilitates the site-specific recombination at the attP site, and the full plasmid is incorporated 
into the genome. The attL and attR sites on either side of the plasmid DNA are each formed from 
half the attP and half the attB site. Sites of PCR primers for junction verification are shown in red. 
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Recombineering oligos were designed to insert a viral att site at the desired location in the 
genome. Oligos included the final 70 bases of the gene of interest (before the stop codon), the att 
site (sequence: GGTTTGTCTGGTCAACCACCGCGGTCTCAGTGGTGTACGGTACAAACC), 
and the 70 bases following, including the stop codon. Directionality of the oligo was chosen based 
on the location of the gene of interest in either the right or left replicore, so that the oligo could 
be treated as an Okazaki fragment and incorporated into the genome on the lagging strand. 
 
Checking PCR 
Verification of transformations was done via PCR. PCR cycling protocol was as below. 
Annealing temperature was calculated via the NEB Tm calculator. 
  
Figure 2: Depiction of the incorporation of oligo in the ORBIT system. The oligo is treated as an Okazaki 
fragment and incorporated as part of the lagging strand during normal genome replication. The excess 
DNA corresponding to the attP site exists as a loop of unpaired DNA until the second round of 
replication, at which point one of the daughter cells will contain a double-stranded attP site. 
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95° C  30 s 
95° C  30 s 
[annealing temp] 30 s 
72° C  [1 minute for each kb] 
68° C  2-5 min 
10° C  hold 
 
Curing to Remove Recombineering Plasmid 
In order to minimize unintended effects of the recombineering plasmid, isolates that were 
verified to have been successfully tagged were grown up in 5 ml cultures and plated on 7H10 
plates with 15% sucrose. Colonies that grew were then re-streaked on a kanamycin and 
hygromycin plate. Those that grew on hygromycin but not kanamycin were determined to be 
lacking the recombineering plasmid, and were grown in culture and stored as glycerol stock for 
future use.  
 
M. smegmatis Growth in Hypoxia 
Growth in hypoxia was conducted based on the Wayne model (Wayne & Hayes, 1996). 10 
ml liquid cultures were grown under standard conditions to an OD indicating exponential phase, 
and then diluted to an OD of 0.01. 36.5 ml of diluted culture was added to a bottle and sealed 
with a rubber cap, metal cover, and a clamp. The bottles were then secured and incubated at 37° 
C, shaking at 125 rpm, for 42 hours. 
 
Total Protein Extraction 
Each 36.5 ml culture was grown under desired conditions (standard, hypoxia, etc.) to the 
desired OD. Cultures were pelleted in 50 ml conical tubes using the Eppendorf Centrifuge 5810R 
at 4° C for 5 minutes at 3900 rpm. After removal of supernatant, pellets were washed 2x with 7H9 
with Tween 80 and glycerol, but no ADC components. The final pellets were then suspended in 
1 ml PBS + 2% SDS with Amresco protease inhibitor cocktail added to 1x immediately before 
use. Resuspended pellets were transferred to a lysing matrix B tube and placed into an MP 
FastPrep-24™ 5G and bead-beated 4x at 6.5 m/sec, 30 seconds per cycle, with 1-minute 
incubations on ice in between cycles. Tubes were then spun at 13,000 rpm in an Eppendorf™ 
5424 Microcentrifuge. Supernatant was removed, placed in a new screw cap tube, and stored at -
20° C. 
 
Western Blotting 
Western blotting was conducted using Mini-PROTEAN TGX Precast Gels with 50 µl 
wells. Lysates were heated at 95°C for 10 minutes again upon removal from storage. Gels were 
run according to manufacturer instructions, loading 10 µl of Bio-Rad Precision Plus Dual Color 
Ladder and 20-35 µl of lysate combined with 4x sample buffer (20 mM Tris-Cl at pH 6.8, 400 mM 
DTT, 8% SDS, 0.4% bromophenol blue, 40% glycerol). Gels were run at 140 V using the Bio-
Rad Mini-PROTEAN Tetra System. Blotting was conducted using PVDF membrane, and the 
machine was run at 100 V for one hour. Blots were then stained using Ponceau S before blocking 
and imaged on a Bio-Rad Gel Doc XR. They were then blocked using TBS + 3% nonfat milk for 
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30-60 minutes, then incubated with primary antibody (Monoclonal ANTI-FLAG M2 antibody, 
Sigma, F1804-200UG, 1 mg/ml stock, 15 µl in 15 ml blocking solution) overnight at 4°C. They 
were then incubated with secondary antibody (Sigma anti-mouse whole molecule IgG produced 
in rabbit, 1 µl in 30 ml blocking solution) for 30 minutes at room temperature, washed in TBS + 
Tween 20, and then imaged on a Bio-Rad ChemiDoc XRS using the Pierce ECL Plus Western 
Blotting Substrate kit.  
 
Oligo name Function Sequence 
SSS585 Forward primer for 
checking junction between 
genome and rraA gene (used 
as a control to verify 
amplification of genomic 
DNA) 
CAGCCAGAATGGCAGAGCAG 
 
SSS586 Reverse primer for checking 
junction between genome 
and rraA gene 
AAGACCATCCGTGCCGGCAA 
 
SSS1061 Forward primer to verify 
presence of 1.5kb segment 
#1 of pKM444 or pKM461 
CATCCTGACGGATGGCCTTT 
 
SSS1036 Reverse primer to verify 
presence of 1.5kb segment 
#2 of pKM444 or pKM461 
CGGATGACTACCAGGGCT 
 
SSS1037 Forward primer to verify 
presence of 1.5kb segment 
#2 of pKM444 or pKM461 
CTTCGAGATGAGAGCCCTG 
SSS1038 Reverse primer to verify 
presence of 1.5kb segment 
#2 of pKM444 or pKM461 
CGCTAGTTAACCTACGACATC 
 
SSS980 Oligo to incorporate attP 
into rne (msmeg_4626). 
GTGACCAGCGGGTAGAGGGTCAAACTGGCC 
CCCCCCTGGATCTCGCCTGAGACACCGTGAT 
GCTCGTCTAGGTTTGTACCGTACACCACTGA 
GACCGCGGTGGTTGACCAGACAAACCGTCGT 
GGCTGGGCGGCCCCGCCGGACGTGCCGCGG 
CCCGGCGGCGCACCCGTGCGCGCGGCGCCG 
TCACC 
Table 2: Oligos
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SSS981 Oligo to incorporate attP 
into a putative RNA helicase 
gene (msmeg_1540). 
CGCACGTGGTGGTGCGCACCGGGGTGGACG 
CGGCCGCAGGCCGCGCCGCTCCAACGAGTC 
GTCCGCGCGCGGTTTGTCTGGTCAACCACCG 
CGGTCTCAGTGGTGTACGGTACAAACCTAGA 
GACGCGCGAAATGTGCGGTCCCACCCGACCT 
CTCCATACCGGGTGGGACCGCACAGGCATTT 
GTGG 
SSS982 Oligo to incorporate attP 
into the RNase J gene 
(msmeg_2685). 
AGGTGCTCAAGCTCGCGGGCCTGTTCACCGG 
CGGGATCCTGCTGCTGGCGGGTTGAGCTCAG 
ATCGCTCAGGTTTGTACCGTACACCACTGAGA 
CCGCGGTGGTTGACCAGACAAACCGATCTCTA 
TGACGGTCGGGACGATCATCGGCTGCCTGCG 
GTAGGTCTCGCCCACCCACTTGCCGACCGTG 
SSS1008 Forward primer for L 
junction to check 
incorporation of Orbit 
plasmid following 
msmeg_2684. To be used 
with SSS1009. 
CAGAAGGTTGAGCGCGAA 
 
SSS1009 Reverse primer for L 
junction to check 
incorporation of Orbit 
plasmid. 
CCTGGTATCTTTATAGTCCTGTCG 
 
SSS1010 Forward primer for R 
junction to check 
incorporation of Orbit 
plasmid. 
TGCACGGGACCAACATCTTCGTGG 
 
SSS1011 Reverse primer for R 
junction to check 
incorporation of Orbit 
plasmid following 
msmeg_2684. To be used 
with SSS1010. 
TGTCGCGTTGGAGGTGCTCAA 
 
 
SSS623 
 
Forward primer near end of 
msmeg_4626 to check 
incorporation of Orbit 
plasmid. To be used with 
SSS1009. 
ATCGACGAGCAGCTCGCGAA 
 
11 
 
SSS1090 
 
Reverse primer for R 
junction to check 
incorporation of Orbit 
plasmid following 
msmeg_4626. To be used 
with SSS1010. 
CTTGCCGCCGGTCTTGACGA 
 
SSS1097 
 
Forward primer for L 
junction to check 
incorporation of Orbit 
plasmid following 
msmeg_1540. To be used 
with SSS1009. 
TTCGGTGAGCCCATTCGC 
 
SSS1098 
 
Reverse primer for R 
junction to check 
incorporation of Orbit 
plasmid following 
msmeg_1540. To be used 
with SSS1010. 
AACGCGGTGCGTGACGGGT 
 
SSS1099 
 
Reverse primer to pair with 
SSS1097: post-msmeg_1540 
genomic DNA. To provide 
positive confirmation of a 
missing insert if necessary. 
TGTTCAGCCTCGGCAACG 
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Results  
Strain construction 
Three strains of M. smegmatis were constructed via a novel recombineering-based approach 
developed by Kenan Murphy (UMass Medical School) and diagramed in Figures 1 and 2. Proteins 
were tagged at the C-terminal end with FLAG and DAS+4 (McGinness et al., 2006). The proteins 
tagged were RNase J (msmeg_2685), RNase E (msmeg_4626), and a putative helicase 
(msmeg_1540); these proteins were chosen as candidates because they are known or suspected to 
be involved in RNA degradation, and none of them appears to be part of an operon. The absence 
of an operon is significant because an entire plasmid is inserted into the genome following the 
gene, with potential to disrupt downstream genes if they are co-transcribed with genes upstream 
of the insertion or regulated by elements upstream of the insertion.  
Each strain was evaluated for successful incorporation of the plasmid by PCR. The primers 
constructed for PCR were designed to amplify the portion of DNA surrounding the junctions 
both upstream and downstream of the site of recombination. PCR products were then purified 
and sequenced. For the RNase J strain, both junctions were confirmed, while for the RNase E 
and helicase strains, only the downstream junction was confirmed. PCR was attempted for the 
upstream junctions for these strains several times, using several sets of primers annealing to 
different positions, but none of these yielded bands. 
Though the presence of the tag was verified, the RNase J strain did not yield a specific band 
on a western blot, under any conditions. The helicase strain produced a faint specific band (Figure 
4). The RNase E strain showed a strong specific band (Figure 3), suggesting that this strain could 
be used to assess condition-dependent changes in RNase E protein levels. 
 
 
RNase E protein abundance appears to be decreased in hypoxic cultures 
To determine if RNA degradation enzymes are downregulated in quiescent M. smegmatis, we 
compared RNase E abundance in log phase and hypoxic cultures. Two isolates of the RNase E 
strain were tested, with two biological replicates for each isolate in each condition. Each isolate 
originated from a distinct colony on a transformation plate, and both had been “cured” by 
counterselection on sucrose to ensure absence of the recombineering plasmid. Cultures were 
grown under aerobic and hypoxic conditions, and the cells were lysed during mid-log phase for 
the aerobic cultures, and 42 hours after sealing the bottles for the hypoxic cultures. Unpublished 
data from experiments performed by other lab members indicate that growth ceases 
approximately 24 hours after sealing the bottles. Lysate was used for total protein quantification 
and western blotting. When loading the gel for blotting, the bacterial lysates were normalized 
based on protein concentration, in order to ensure that the same quantity of total protein was 
being loaded in each well. 
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 When normalized to the optical densities of the cultures from which they were derived, the 
total protein concentrations were modestly decreased in hypoxia compared to log phase (Figure 
4). This suggests that protein content per cell may be slightly lower in hypoxia. However, the 
decrease only reached statistical significance for one of the three strains. 
On the western blot (Figure 5), the bands from the hypoxic cultures were substantially lighter 
than those from the log phase cultures. This reduction of band intensity in hypoxia persists 
regardless of discrepancies in apparent protein load (Figure 5B). As the blot was normalized to 
total protein level and hypoxic cultures were found to have decreased protein concentrations, the 
tagged protein appears to comprise a decreased proportion of the total protein present in the 
cultures, and fewer copies of the protein per cell are present. 
A second band also appeared below the first, with a faint presence in the lysates derived 
from log phase cultures and a much stronger presence in those from hypoxic cultures.  
A similar experiment was done with the helicase-tagged strains, but the experimental blot 
comparing hypoxic and aerobic conditions was inconclusive, with only a faint band appearing for 
the aerobically grown strain in the image resulting from an hour-long exposure (data not shown). 
Because the signal from the aerobic condition was so weak, we could not conclude with 
confidence that the signal from the hypoxic samples was in fact decreased. 
Figure 3: Western blotting reveals a specific band for the RNase E-FLAG strain.  All three tagged strains 
were grown in aerobic conditions. (A) Anti-FLAG western blot. Image including ladder has been overlaid. 
Positive controls were acquired from Christina Baer at UMass Medical School. (B) Ponceau S staining to 
verify equal total protein loading. Expected size for positive controls (Venus fluorescent protein, three 
different expression levels) was 27 kDa. Expected sizes for experimental proteins were 60 kDa for RNase 
J, 112 kDa for RNase E, and 49 kDa for helicase. 
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Figure 4: Comparison between normalized protein concentrations in log phase 
and hypoxic cultures, including wild type strains and the two RNase E tagged 
isolates, SS-M_0249 and SS-M_0250. Two-sample T test assuming equal 
variance. Error bars represent standard deviation. 
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Figure 5: RNase E protein abundance appears to be reduced in hypoxia. (A) Western blot with RNase E tagged 
strains in hypoxia. 8-minute exposure is shown. A negative control (unmodified mc2155) and two isolates of each 
strain were analyzed, with two replicates of each strain in each experimental condition. (B) Ponceau S staining confirms 
that the differences in panel A cannot be explained by unequal protein loading. Expected size for RNase E is 112 
kDa. 
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Discussion 
 
The RNase E tagged strain appears to show some downregulation of RNase E protein under 
hypoxic conditions, which would provide evidence supporting the hypothesis that regulation of 
RNA degradation proteins affects mRNA half-lives in quiescent mycobacteria. The appearance 
of a second, smaller band that is stronger in hypoxia even suggests a possible mechanism of 
protein regulation: cleavage of proteins could result in a smaller protein that has altered properties 
but still shows up on a western blot.  
Though the potential implications of the results are noteworthy, the failure to confirm the 
upstream junction of the tag is a serious concern. Since the adjustment of primers and PCR 
conditions yielded no results, poor PCR quality is unlikely. The size of the protein that appears on 
the western blot is also a concern, though aberrant migration of RNase E (specifically, running as 
a larger protein) has been previously reported in M. tuberculosis (Zeller et al., 2007) and E. coli 
(Casaregola et al., 1994). According to Caseregola et al., the discrepancy in the E. coli protein may 
be due to the high quantity of highly charged residues in the C-terminal region of the protein. The 
M. smegmatis RNase E appears to have this same pattern of many highly charged residues in this 
area. However, some follow-up work in process (currently being conducted by other members of 
the Shell lab) suggests that attempts to incorporate a plasmid following the RNase E-encoding 
gene results in a large (3kb or greater) duplication of DNA between the gene of interest and the 
incorporated plasmid. Based on this information, it is currently impossible to come to a conclusion 
regarding what is being visualized on the gel. 
The intent of the Shell lab is to continue moving forward with this research. Based on the 
assumption that tagging RNase E at the C terminal end (the present technique) yields problematic 
results, further research may begin with tagging at the N terminal end.  
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